Depomed to Report First-Quarter 2018 Financial Results on Thursday, May 10, 2018
May 03, 2018 08:00 ET
|
Depomed, Inc.
LAKE FOREST, Ill., May 03, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will release first-quarter 2018 financial results on Thursday, May 10, 2018, before the open...
Depomed Announces the Appointment of John B. Thomas as Senior Vice President, Investor Relations and Corporate Communications
April 17, 2018 16:05 ET
|
Depomed, Inc.
NEWARK, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced the appointment of John B. Thomas as Senior Vice President, Investor Relations and Corporate...
Depomed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
April 09, 2018 08:00 ET
|
Depomed, Inc.
NEWARK, Calif., April 09, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) made a grant on April 2, 2018 of 91,324 restricted stock units (“RSUs”) and 91,324 target performance stock units...
Depomed Announces the Appointment of Stan Bukofzer, M.D. as Senior Vice President and Chief Medical and Scientific Officer
April 02, 2018 16:05 ET
|
Depomed, Inc.
NEWARK, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced the appointment of Stan Bukofzer, M.D., as Senior Vice President, Chief Medical and Scientific Officer,...
Depomed Announces New Corporate Headquarters
March 19, 2018 08:00 ET
|
Depomed, Inc.
NEWARK, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced it has signed a lease for its new corporate headquarters at 100 South Saunders Road in Lake Forest,...
Depomed to Present at Healthcare Conferences in March
March 06, 2018 16:04 ET
|
Depomed, Inc.
NEWARK, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that members of senior management will participate in fireside chats at the following healthcare...
Depomed Announces Fourth Quarter and Full Year 2017 Financial Results
February 27, 2018 16:03 ET
|
Depomed, Inc.
- Annual Net Revenues of $381 Million - - Collegium, Slán Transactions and Expanded Neurology Field Force Position Company for Improved Profitability in 2018 and Beyond – - New Corporate...
Depomed to Report Fourth Quarter Fiscal Year 2017 Financial Results on Tuesday, February 27, 2018
February 20, 2018 16:05 ET
|
Depomed, Inc.
NEWARK, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will release fourth quarter fiscal year 2017 financial results on Tuesday, February 27, 2018,...
Depomed to Present at Healthcare Conferences in February
February 07, 2018 16:00 ET
|
Depomed, Inc.
NEWARK, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) --
Depomed, Inc. (NASDAQ:DEPO) today announced that members of senior management will participate in fireside chats at the following...
Depomed Announces Closing of NUCYNTA Commercialization Agreement With Collegium Pharmaceutical
January 10, 2018 09:00 ET
|
Depomed, Inc.
NEWARK, Calif., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced the closing of its previously disclosed Commercialization Agreement (“Agreement”) for the U.S. rights to...